Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Merck |
---|---|
Information provided by: | Merck |
ClinicalTrials.gov Identifier: | NCT00211601 |
The purpose of this study is to assess whether timely feedback to providers on patient experiences with delayed chemotherapy induced nausea and vomiting (CINV) lead to differences in patient outcomes for subsequent cycles.
Condition | Intervention |
---|---|
Chemotherapy Induced Nausea and Vomiting |
Behavioral: Disease Management Assessment |
Study Type: | Interventional |
Study Design: | Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Parallel Assignment |
Official Title: | Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (C-PHONE) |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Study ID Numbers: | 2005_072 |
Study First Received: | September 13, 2005 |
Last Updated: | September 13, 2005 |
ClinicalTrials.gov Identifier: | NCT00211601 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Vomiting Nausea |